Fig. 4From: Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecanThe correlation between PFS and the expression value of (a) PSKH1, (b) TLK2 and (c) PHKG2Back to article page